A US cohort study suggested that metformin cessation was associated with increased dementia incidence. The cohort consisted of 12 220 early terminators and 29 126 routine users, respectively (women 46.2% and 46.6%, respectively; mean age at start of first metformin prescription 59.4 and 61.1 years, respectively). Early terminators had 1.21 times the hazard of dementia diagnosis compared with routine users (hazard ratio, 1.21). Mediation analysis indicated that the association was not mediated by insulin use 1 or 5 years after metformin cessation, and minimally mediated by HbA1c level at 1 year after metformin cessation, suggesting that the association was largely independent of changes in HbA1c level and insulin usage. The findings are in line with other observational studies showing an association between metformin use and lower dementia incidence, with potential implications for diabetes treatment in late life. Source: https://jamanetwork.com/
Two randomized, controlled trials evaluated the efficacy and safety of obicetrapib, an oral cholesteryl ester…
A UK longitudinal associations study revealed that hyperlipidemias and inflammation independently and together raise the…
A study shows that eating a lot of highly processed foods is likely causing a…
Two recent studies highlight the importance of physical activity volume and intensity in reducing cardiovascular…
A prospective UK cohort study found that both self-reported average or brisk walking pace and…
A U.S. randomized clinical trial found that 4:3 intermittent fasting (IMF) led to slightly greater…
This website uses cookies.